CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc., a leader in nanopharmaceuticals, today announced that the Company’s chief executive, Oliver Fetzer, Ph.D., will present at the BioPharm AmericaTM conference being held in Boston, Massasachusetts, from September 15-17, 2010. The premier pharmaceutical partnership conference has joined forces with MassBio Investors Forum to bring together pharmaceutical industry executives and life science investors for one of the largest and most productive partnering events. Dr. Fetzer will brief attendees on Cerulean’s key accomplishments and positive momentum.
